You have to learn to "look for trouble" when you work"
Release time:
2020-08-14
When doing a job, one must learn to "look for trouble"
once heard someone complain that he entered the factory in the same year as XXX and worked in the same team and group in the same position. As a result, after working year after year, the family became a big leader and he was still a front-line small worker. To this, the "big leader" replied simply: "this is because I was reading and studying when you were playing cards and chatting." Finding something to do in his spare time changed his life.
There are many similar examples around us. The reason why the reserve talents selected by the company twice can stand out from a large number of employees with the same education background and the same position is of course personal ability. But where does the ability come from? Of course, it comes from practice. It depends on constantly doing things, even doing some seemingly unnecessary work, constantly exercising and improving, and finally opening the gap with peers and becoming the focus of attention of superiors.
There is a line in Kung Fu Panda: If you only do your part, you will never improve. Although this movie is a comedy cartoon, but this sentence contains great wisdom.
We often hear some complaints from newcomers: the master is too worried about us and doesn't let us do anything, which makes our position very awkward; the company doesn't pay enough attention to the newcomers, doesn't arrange enough workload for us, doesn't have enough exercise space... and so on. The words of the "old people" are: I have finished all the work at hand, it's not that I don't want to do more, the problem is that the leader didn't arrange it for me; that thing is obviously the responsibility of others, I'm afraid it's not appropriate for me to do it... and so on. These "reasons" seem quite reasonable at first glance, but they are somewhat specious when considered. Leisure is a stage that every employee has gone through. The only difference is that some people have nothing to do and some people have nothing to do. Why? It is not the work in front of us that counts as "things", nor is it the things arranged by the leaders that are "things". The industry characteristics, development direction, business composition, knowledge structure and business skills required by the position are all important factors that will affect career growth. Without accumulation, there will be no vision and vision, and the ability to surpass others will be impossible to talk about. Even if what can be done and should be done is right in front of us, we may not be able to find out. How can we prove ourselves and pursue success? Therefore, "looking for things" is also a kind of ability, and it is a kind of ability that can make us grow quickly and attract attention. Passively waiting for the master to command and lead to arrange will not only miss the opportunity to learn and exercise, but also lose the confidence and patience of your peers.
Learn to "look for things", take the initiative to participate in work, take the initiative to find problems, take the initiative to think about problems, take the initiative to solve problems, take the initiative to take responsibility, take the initiative to take the responsibility of the outside... In this kind of self-driven active work, not only is the way of rapid growth and development, but also can let people from the monotonous boring work constantly find freshness. The employees who can help enterprises solve problems and take the initiative to take responsibility are precisely what managers like and pay most attention.
Many parents said, "Don't let your children lose at the starting line", so many interest classes and improvement classes "oppress" children and parents together. When young people take up their posts and stand on the same starting line as their peers, if they lack the consciousness and ability to "look for trouble", I am afraid they will still lose. (also said)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31